Print
 


Glossary
.................................................................................

Source: Modified from Medline Plus




cell proliferation

Increase in the number of cells as a result of cell division

chemotherapy

The use of chemical agents in the treatment or control of disease or mental disorders

clinical trials

Medical research studies conducted on human subjects to answer scientific questions and to find better ways to prevent, detect or treat diseases

efficacy

The ability of a drug to control or cure an illness or disease

FDA

Food and Drug Administration

formulation

Incorporation of a drug into a relevant delivery vehicle, such as a gel

GMP

Good Manufacturing Process

intravenous (IV)

Situated within, performed within, occurring within, or administered by entering a vein - injection of a drug into the bloodstream through a vein

intra-cavitary (IC)

Situated or occurring within a body cavity (i.e. treatment characterized by the insertion of substances in a cavity)

IND

Investigational new drug

kinase

An enzyme that catalyzes the transfer of phosphate groups from a high-energy phosphate-containing molecule (as ATP or ADP) to a substrate

malignant

Cancerous - of unfavorable prognosis

melanocytes

An epidermal cell that produces melanin

metastases, metastasise

Transfer of a disease-producing agency (e.g. cancer cells) from an original site of disease to another part of the body with development of a similar lesion in a new location

mutation

A relatively permanent change in hereditary material (gene) involving a physical change in chromosome relations

pathway

A system of proteins that work together

pharmacokinetics

The study of the bodily absorption, distribution, metabolism and excretion of drugs

pharmacology

Evaluation of the activity of the drug in various cell systems and animal models of the disease

phase I

Clinical trial designed to determine the safety and appropriate dose

phase II

Clinical trial designed to measure the safety and efficacy

phase III

Clinical trial designed to test new treatment and measure efficacy as well as safety as compared to the standard of care

progression

A trend or shift toward a high, more severe state - increase of tumour size (opposite of regression)

receptor

A chemical group or molecule (as a protein) on the cell surface or in the cell interior that has an affinity for a specific chemical group, molecule, or virus

regimen

A systematic plan designed to improve and maintain the health of a patient

regression

A trend or shift toward a lower, less severe or less perfect state - reduction in the size of tumour (opposite of progression)

therapeutic

Of or relating to the treatment of disease or disorders by remedial agents or methods

therapy (therapies)

Treatment(s)

toxicity

The quality, state, or relative degree of being toxic or poisonous

toxicology

Evaluation of the safety profile of a drug

tumour

An abnormal benign or malignant mass of tissue that is not inflammatory, arises without obvious cause from cells of preexistent tissue, and possesses no physiological function



© Peplin 2008